Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-004160
Filing Date
2025-03-31
Accepted
2025-03-31 16:15:43
Documents
129
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fbio-20241231x10k.htm   iXBRL 10-K 5109489
2 EX-4.4 fbio-20241231xex4d4.htm EX-4.4 114973
3 EX-19.1 fbio-20241231xex19d1.htm EX-19.1 80971
4 EX-21.1 fbio-20241231xex21d1.htm EX-21.1 7705
5 EX-23.1 fbio-20241231xex23d1.htm EX-23.1 5684
6 EX-31.1 fbio-20241231xex31d1.htm EX-31.1 15069
7 EX-31.2 fbio-20241231xex31d2.htm EX-31.2 14815
8 EX-32.1 fbio-20241231xex32d1.htm EX-32.1 7404
9 EX-32.2 fbio-20241231xex32d2.htm EX-32.2 7324
  Complete submission text file 0001558370-25-004160.txt   20851270

Data Files

Seq Description Document Type Size
10 EX-101.SCH fbio-20241231.xsd EX-101.SCH 158385
11 EX-101.CAL fbio-20241231_cal.xml EX-101.CAL 112195
12 EX-101.DEF fbio-20241231_def.xml EX-101.DEF 640692
13 EX-101.LAB fbio-20241231_lab.xml EX-101.LAB 1112423
14 EX-101.PRE fbio-20241231_pre.xml EX-101.PRE 962636
132 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20241231x10k_htm.xml XML 3708867
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35366 | Film No.: 25793457
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)